Skip to main content
OpenTrials

Clinical trial condition

Mood Disorders

Explore clinical trials studying Mood Disorders. Study availability and eligibility vary by location and protocol.

4,272 public trials 601 recruiting studies
Refine in advanced search Browse all conditions

Mood Disorders trial results

Completed

Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia

NCT04437342

Conditions
Behavior, Behavioral Symptoms, COVID-19, +23 more
Locations
  • "Elena Venizelou" General and Maternity Hospital of Athens Athens, Attica, Greece
  • Aretaieio University Hospital Athens, Attica, Greece
  • Alexandra Genaral Hospital Athens Athens, Greece
  • University of Ioannina Health Science Ioannina, Greece
View Trial Details
Completed

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

NCT02371980

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • NoesisPharma Phoenix, Arizona, United States
  • SW Biomedical Research, LLC Tucson, Arizona, United States
  • CNS Research Science, Inc. Cerritos, California, United States
  • Collaborative Neuroscience Network, LLC Garden Grove, California, United States
View all 79 locations
View Trial Details
Completed

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

NCT00825539

Conditions
Anxiety Disorders, Bipolar Disorder, Bipolar and Related Disorders, +4 more
Locations
  • West LA VA Healthcare Center (UCLA) Los Angeles, California, United States
  • Department of Psychiatry & Behavioural Sciences, Feinberg School of Medicine (Northwestern University) Chicago, Illinois, United States
  • Maryland Psychiatric Research Centre, Spring Grove Hospital Grounds Baltimore, Maryland, United States
  • Massachusetts General Hospital (Freedom Trail Clinic) Boston, Massachusetts, United States
View Trial Details
Completed

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

NCT01110902

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • University of Alabama at Birmingham, Department of Psychiatry Birmingham, Alabama, United States
  • ATP Clinical Research Costa Mesa, California, United States
  • Valley Clinical Research El Centro, California, United States
  • Collaborative Neuroscience Network Garden Grove, California, United States
View all 45 locations
View Trial Details
Completed

Study to Promote Innovation in Rural Integrated Telepsychiatry

NCT02738944

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +5 more
Locations
  • Lee County Cooperative Clinic Marianna, Arkansas, United States
  • Boston Mountain Rural Health Centers Marshall, Arkansas, United States
  • East Arkansas Family Health Center West Memphis, Arkansas, United States
  • InterCare Community Health Network Bangor, Michigan, United States
View all 13 locations
View Trial Details
Completed

A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)

NCT00463242

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site National City, California, United States
  • Novartis Investigative Site Orange, California, United States
  • Novartis Investigative Site Pasadena, California, United States
View all 47 locations
View Trial Details

Related conditions